Bionic Vision Technologies
Bionic Vision Technologies is a privately held Australian medical device company founded in 2010 that develops visual prostheses to restore vision in blind individuals, operating from Melbourne in the neuroprosthetics and bionic contact lenses market segments.
- Company typePrivate
- Founded2010
- HeadquartersMelbourne, Australia
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bionic Vision Technologies does
Bionic Vision Technologies is a privately held Australian medical device company founded in 2010 and headquartered in Melbourne, Australia. The company develops visual prostheses designed to restore functional vision to individuals who are blind, operating within the neuroprosthetics and bionic contact lenses market segments. Its core work targets retinal diseases and visual impairment through prosthetic device development, addressing an addressable market projected to reach $0.53 billion by 2030 across augmented reality, health monitoring, and vision correction applications.
The company operates with a lean team of 1-10 employees led by CEO Ash Attia, Executive Chairman Robert Klupacs, COO Adrian Oates, CTO Brian Gordon, and directors Er Gad Gold and Andrew Rudge. Its technology appears to be at the research and development stage, as no commercial products, pricing models, regulatory clearances, or manufacturing capabilities are disclosed in available sources. The company has been recognized through the MedTech Innovator accelerator program (2014) and received $18 million in Series 2 funding in April 2017 from China Huarong International Holdings and State Path Capital Limited.
The company's business model is not publicly disclosed, with no revenue figures, pricing structures, customer segments, or go-to-market details available in the input data. Operating status is confirmed as active based on inclusion in current neuroprosthetics market reports, but no products, patents, partnerships, certifications, or geographic markets served are explicitly documented. The lack of disclosed post-2017 activity limits visibility into current commercialization progress, and the company should be assessed as a pre-commercial, R&D-stage medical device venture in a capital-intensive regulatory pathway.
Bionic Vision Technologies firmographics
Firmographics- Name
- Bionic Vision Technologies
- Website
- https://bionicvis.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Bionic Vision Technologies is a privately held Australian medical device company founded in 2010 that develops visual prostheses to restore vision in blind individuals, operating from Melbourne in the neuroprosthetics and bionic contact lenses market segments.
- Ownership category
- akta.pro rank
Bionic Vision Technologies industry classification
Industry- Product category
- Visual Prosthetics / Bionic Eye Systems
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Low Vision & Assistive Vision Devices (Magnifiers, Electronic Video Magnifiers, Wearable Vision Aids) (HLAHAJAN)
- akta.pro secondary industry
- Vitreoretinal Surgical Devices (Vitrectomy Systems, Endolaser, Illumination, Tamponades) (HLAHAJAJ)
Keywords
Where Bionic Vision Technologies is headquartered
LocationHeadquarters
- HQ city
- Melbourne
- HQ country
- Australia
- HQ region
- Oceania
Markets served
Bionic Vision Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain
Bionic Vision Technologies product offering
Product offeringCore offering
Bionic Vision Technologies develops visual prostheses designed to restore functional vision to people blinded by retinal degenerative diseases. The company's core offering is a bionic eye system that uses electrical stimulation of the retina to produce a sense of vision in patients who have lost sight. The company is based in Melbourne, Australia, and is in the development and clinical-trial stage of bringing this medical device to market.
Differentiator
Problem solved
Functional benefit
Products and services
- Bionic Eye Visual Prosthesis System
Companies that use Bionic Vision Technologies
Customer profileIdeal customer profiles1 record
Bionic Vision Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Bionic Vision Technologies partnerships and signals
Strategic signalScale indicators1 record
Recent moves2 records
Expansion highlights3 records
Bionic Vision Technologies competitors and assessment
Company assessmentDirect peers
- Cortigent (formerly Second Sight Medical Products): Cortigent is the most direct competitor in visual prosthetics, having developed and commercialized the Argus II retinal prosthesis system. It serves the same target population of patients with retinitis pigmentosa and outer retinal degeneration.
- Pixium Vision: Pixium Vision is a French company developing the Prima retinal prosthesis system for age-related macular degeneration. It is a direct peer in the visual prosthesis space targeting the same patient populations with a similar technological approach.
- Retina Implant AG: Retina Implant AG developed subretinal implants for retinitis pigmentosa patients, representing a direct competitor with similar retinal stimulation technology and target indications.
Emerging players
- Nano Retina: Nano Retina is an Israeli company developing the NR600 implantable artificial retina, addressing the same blindness-from-retinal-degeneration market with a miniaturized implant approach.
- iBionics (Canadian company): iBionics is an emerging player developing diamond-based retinal implants to restore vision. It addresses the same blindness market with a differentiated electrode technology.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Bionic Vision Technologies social profiles
Digital presenceBionic Vision Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bionic Vision Technologies leadership team
Management profileNumber of profiles
Profiles6 records
Bionic Vision Technologies funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bionic Vision Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bionic Vision Technologies
What does Bionic Vision Technologies do?
Bionic Vision Technologies develops visual prostheses designed to restore functional vision to people blinded by retinal degenerative diseases. The company's core offering is a bionic eye system that uses electrical stimulation of the retina to produce a sense of vision in patients who have lost sight. The company is based in Melbourne, Australia, and is in the development and clinical-trial stage of bringing this medical device to market.
When was Bionic Vision Technologies founded?
Bionic Vision Technologies was founded in 2010. It employs 1 to 10 people.
Where is Bionic Vision Technologies based?
Bionic Vision Technologies is headquartered in Melbourne, Australia, in the Oceania region.
Who are Bionic Vision Technologies's main competitors?
Direct peers on record are Cortigent (formerly Second Sight Medical Products), Pixium Vision and Retina Implant AG. Emerging players are Nano Retina and iBionics (Canadian company).
Does Bionic Vision Technologies have an API?
No public API is recorded for Bionic Vision Technologies.
What industry is Bionic Vision Technologies in?
Bionic Vision Technologies's product category is Visual Prosthetics / Bionic Eye Systems. Its primary akta.pro industry code is HLAHAJAN, Low Vision & Assistive Vision Devices (Magnifiers, Electronic Video Magnifiers, Wearable Vision Aids), with a secondary code of HLAHAJAJ, Vitreoretinal Surgical Devices (Vitrectomy Systems, Endolaser, Illumination, Tamponades). Its NAICS code is 334510 and its SIC code is 3841.